Using past patient data to plan radiation treatment for cervix cancer
Uses past imaging and outcome data from cervix cancer patients to build a computer tool.
Plain-language title generated from the registry record
Registry title: Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer
Key facts
- Where
- Navi Mumbai, IndiaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 90 years old?
Source: NCT05102240, who can take part
Where in India
- Advanced Centre of Treatment Research and Education In Cancer,Tata Memorial CentreNavi Mumbai, IndiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Tata Memorial Hospital
- Trial code
- NCT05102240
- Record updated
- 20 February 2026
- Original description
Retrospective study utilizing patient data to develop and validate Machine Learning application. Available imaging data sets of patients who have completed treatment will be used to develop Normal tissue complication probability and Tumour control probabilityRead full original descriptionShow less
Developing Clinical High Efficiency Platforms for Individualised Treatment Through Integration of Advanced Radiation Technology, Quantitative Imaging and Molecular Biology and Machine Learning for Treatment of Cervix Cancer.
Retrospective study utilizing patient data to develop and validate Machine Learning application. Available imaging data sets of patients who have completed treatment will be used to develop Normal tissue complication probability and Tumour control probability
Hypothesis Integrating existing radiation treatment information, quantitative imaging and patient outcome data from completed and ongoing clinical trials will allow development of knowledge based systems for efficient treatment delivery and allow selection of patients for intensified treatment approaches in cervix cancer.
Inclusion: For Aim 1 and Aim 3:; Patients treated within ongoing and completed clinical trials of chemoradiation and brachytherapy for cervix cancer with access to MRI/CT images at the time of diagnosis and brachytherapy For Aim 2; Patients undergoing postoperative or definitive radiotherapy and treated within trials of postoperative or definitive RT.
Exclusion: Lack of disease or toxicity outcomes; Lack of images in the hospital database.